Search for dialysis centres here

Find a centre Log in to explore the world's most comprehensive database of dialysis centres for free!

Jobs in dialysis

dialysis.team.logo.small.000 Professional dialysis recruitment 

 

Eisai's Lenvima gets FDA breakthrough status for renal cell carcinoma - Pharmaceutical Business Review PDF Print

Pharmaceutical Business Review
Eisai's Lenvima gets FDA breakthrough status for renal cell carcinoma
Pharmaceutical Business Review
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Eisai's in-house developed new anticancer agent Lenvima (lenvatinib mesylate, lenvatinib) for the potential indication of advanced and/or metastatic renal cell ...
Eisai's Lenvima receives Breakthrough Therapy designation for renal cell carcinoma European Pharmaceutical Review
FDA grants breakthrough drug designation to Lenvima for advanced RCC Healio
Eisai's Lenvima breakthrough therapy for new indication PharmaTimes

all 8 news articles »

...
 
Share |

Dialysis travel

Dialysis information

Global Dialysis

Copyright © 2025 Global Dialysis. All Rights Reserved.